Edgewise Therapeutics Inc
For the period ended Jun 30, 2024. Filed Aug 8, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 8, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
See Exhibit Index.
EXHIBIT INDEX
| · · · · · · · · · | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| · · · · Incorporated by Reference | ||||||||||
| ExhibitNumber | | Exhibit Description | | Form | | File No. | | Exhibit | | Filing Date |
| | | | | | | | | | | |
| 3.1 | | Amended and Restated Certificate of Incorporation of the Registrant | | Filed herewith | | | | | | |
| | | | | | | | | | | |
| 4.1 | | Form of Indenture | | S-3ASR | | 333-279299 | | 4.4 | | May 10, 2024 |
| | | | | | | | | | | |
| 10.1 | | Sales Agreement, dated May 10, 2024, by and between the Registrant and Leerink Partners LLC | | S-3 | | 333-279299 | | 1.2 | | May 10, 2024 |
| | | | | | | | | | | |
| 31.1 | | Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | | Filed herewith | | | | | | |
| | | | | | | | | | | |
| 31.2 | | Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 14d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | | Filed herewith | | | | | | |
| | | | | | | | | | | |
| 32.1† | | Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | | Furnished herewith | | | | | | |
| | | | | | | | | | | |
| 32.2† | | Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | | Furnished herewith | | | | | | |
| | | | | | | | | | | |
| 101.INS | | Inline XBRL Instance Document | | Filed herewith | | | | | | |
| | | | | | | | | | | |
| 101.SCH | | Inline XBRL Taxonomy Extension Schema Document | | Filed herewith | | | | | | |
| | | | | | | | | | | |
| 101.CAL | | Inline XBRL Taxonomy Extension Calculation Linkbase Document | | Filed herewith | | | | | | |
| | | | | | | | | | | |
| 101.DEF | | Inline XBRL Taxonomy Extension Definition Linkbase Document | | Filed herewith | | | | | | |
| | | | | | | | | | | |
| 101.LAB | | Inline XBRL Taxonomy Extension Label Linkbase Document | | Filed herewith | | | | | | |
| | | | | | | | | | | |
| 101.PRE | | Inline XBRL Taxonomy Extension Presentation Linkbase Document | | Filed herewith | | | | | | |
| | | | | | | | | | | |
| 104 | | The cover page for the Company’s Quarterly Report on Form 10-Q has been formatted in Inline XBRL and contained in Exhibit 101 | | Filed herewith | | | | | | |
Ù Indicates management contract or compensation plan
†The certifications attached as Exhibits 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are deemed furnished and not filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.